Myomo (MYO) Liabilities and Shareholders Equity (2016 - 2025)
Myomo (MYO) posted Liabilities and Shareholders Equity of $38.6 million for Q4 2025, up 13.38% on a QoQ basis from $34.1 million in Q3 2025, and down 8.54% year-over-year from $42.2 million in Q4 2024.
Myomo (MYO) Liabilities and Shareholders Equity (2016 - 2025) Analysis & Trends
Myomo's Liabilities and Shareholders Equity history runs 10 years deep, the most recent figure standing at $38.6 million for Q4 2025.
- Quarterly Liabilities and Shareholders Equity fell 8.54% year-over-year to $38.6 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $152.3 million (up 66.82% YoY) and the FY2025 annual result came in at $38.6 million, down 8.54% from the prior year.
- Liabilities and Shareholders Equity was $38.6 million for Q4 2025 at Myomo, up from $34.1 million in the prior quarter.
- Across five years, Liabilities and Shareholders Equity topped out at $42.2 million in Q4 2024 and bottomed at $10.2 million in Q4 2022.
- A 5-year average of $21.7 million and a median of $17.3 million in 2021 frame the typical range for Liabilities and Shareholders Equity.
- Annual changes were most pronounced in 2022 — Liabilities and Shareholders Equity sank 49.43% — and 2024, when it surged 189.71%.
- Myomo's Liabilities and Shareholders Equity stood at $20.1 million in 2021, then sank by 49.43% to $10.2 million in 2022, then soared by 43.49% to $14.6 million in 2023, then jumped by 189.71% to $42.2 million in 2024, then dropped by 8.54% to $38.6 million in 2025.
- Business Quant data shows MYO's Liabilities and Shareholders Equity at $38.6 million in Q4 2025, $34.1 million in Q3 2025, and $38.7 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 110.43 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 46.29 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 93.03 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 44.35 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 13.32 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 6.63 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 31.92 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 37.13 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 10.46 Bn |
| 10 | Myomo | 39.24 Mn | 20.27 Mn | - | 38.64 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 38.64 Mn |
| Sep 30, 2025 | 34.08 Mn |
| Jun 30, 2025 | 38.67 Mn |
| Mar 31, 2025 | 40.87 Mn |
| Dec 31, 2024 | 42.24 Mn |
| Sep 30, 2024 | 16.31 Mn |
| Jun 30, 2024 | 16.19 Mn |
| Mar 31, 2024 | 16.52 Mn |
| Dec 31, 2023 | 14.58 Mn |
| Sep 30, 2023 | 17.05 Mn |
| Jun 30, 2023 | 13.30 Mn |
| Mar 31, 2023 | 13.74 Mn |
| Dec 31, 2022 | 10.16 Mn |
| Sep 30, 2022 | 12.16 Mn |
| Jun 30, 2022 | 14.56 Mn |
| Mar 31, 2022 | 17.98 Mn |
| Dec 31, 2021 | 20.10 Mn |
| Sep 30, 2021 | 17.46 Mn |
| Jun 30, 2021 | 17.71 Mn |
| Mar 31, 2021 | 20.92 Mn |